United States Congress · 119 session · house
HR 2821FDA Modernization Act 3.0
- Latest action
- — Motion to reconsider laid on the table Agreed to without objection.
- Primary sponsor
- Rep. Carter, Earl L. "Buddy" [R-GA-1] (R)
- Health
Sponsors
- Rep. Carter, Earl L. "Buddy" [R-GA-1] (R) · sponsorprimary
Versions
- Reported in House
- Introduced in House
Legislative history
- Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.
- Mr. Guthrie moved to suspend the rules and pass the bill.
- Considered under suspension of the rules. (consideration: CR H4639-4640)
- On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
- Motion to reconsider laid on the table Agreed to without objection.
Official sources
About this page
- Is this the official United States Congress bill page?
- No — this is Billy’s public legislative record for HR 2821. Official source links are listed above when publishers provide them.
- Can I track updates?
- Yes. Sign in to track HR 2821, get alerts, annotate diffs, and export Word work product.